Investment Rating - The investment rating for the beauty and personal care industry is "outperforming the market" [4][22]. Core Insights - The fund allocation ratio for the beauty and personal care industry decreased to 0.14% in Q4 2025, down 0.06 percentage points from Q3 2025, indicating a continued low allocation status [1][3][9]. - The total market capitalization of the beauty and personal care industry reached 255.096 billion yuan in Q4 2025, reflecting a 10.43% decrease from Q3 2025 [1][9]. - The medical beauty sector remains in an over-allocated position, while personal care and cosmetics are in a low allocation zone [2][11]. Summary by Sections Industry Overview - In Q4 2025, the fund allocation ratio for personal care products was 0.03%, down 0.01 percentage points from Q3 2025, with an over-allocation ratio of -0.04% [2][13]. - The cosmetics sector saw a fund allocation ratio of 0.02% in Q4 2025, down 0.02 percentage points from Q3 2025, with an over-allocation ratio of -0.1% [2][13]. - The medical beauty sector's fund allocation ratio was 0.09% in Q4 2025, down 0.03 percentage points from Q3 2025, with an over-allocation ratio of 0.02% [2][13]. Individual Stocks - The top three stocks in the beauty and personal care sector by fund allocation in Q4 2025 were Jinbo Biological, Aimeike, and Baiya Shares, with a total heavy holding ratio of 0.05%, down 0.02 percentage points from Q3 2025 [2][15][19]. - Jinbo Biological had a heavy holding ratio of 0.0163%, Aimeike at 0.0156%, and Baiya Shares at 0.0040% in Q4 2025, all showing a decline compared to Q3 2025 [15][19]. Investment Recommendations - In the context of stabilizing the economy and expanding domestic demand, it is recommended to focus on: 1. Cosmetics and medical beauty: There is significant demand potential in the medium to long term, supported by regulatory policies favoring compliant companies [3][20]. 2. Personal care products: The growing emphasis on health and wellness among consumers suggests opportunities for leading companies with strong R&D capabilities [3][20].

Market Overview - The cosmetics sector experienced a decline of 0.98% on January 30, with Lafang Family leading the drop [1] - The Shanghai Composite Index closed at 4117.95, down 0.96%, while the Shenzhen Component Index closed at 14205.89, down 0.66% [1] Individual Stock Performance - Qingdao Kingking (002094) saw a closing price of 8.75, with an increase of 4.17% and a trading volume of 1.1682 million shares, amounting to a transaction value of 1.02 billion [1] - Lafang Family (603630) closed at 19.21, down 6.38%, with a trading volume of 89,300 shares and a transaction value of 174 million [2] - Shanghai Jahwa (600315) closed at 20.92, down 4.52%, with a trading volume of 163,300 shares and a transaction value of 345 million [2] - Other notable stocks include Beitaini (300957) at 41.89, down 0.85%, and Marubi (603983) at 31.52, down 0.32% [2] Capital Flow Analysis - The cosmetics sector saw a net inflow of 60.2766 million from institutional investors, while retail investors experienced a net outflow of 62.139 million [2] - The main capital inflow was led by Qingdao Kingking with 68.098 million, while retail investors showed significant outflows across various stocks [3] - Shanghai Jahwa had a net inflow of 6.7524 million from institutional investors, but also faced a net outflow of 7.7544 million from retail investors [3]

Core Viewpoint - The Guangzhou government is promoting high-quality development in the cosmetics industry, with significant growth in imports and exports, supported by new customs measures aimed at enhancing efficiency and reducing costs for enterprises [1][2][3] Group 1: Industry Growth - In 2025, Guangzhou's beauty cosmetics and personal care products imports and exports reached 17.34 billion yuan, an increase of 11.2% [1] - Exports accounted for 11.63 billion yuan, growing by 25.2%, maintaining Guangzhou's position as the largest exporter of beauty and personal care products in China, with products reaching over 170 countries and regions across six continents [1] Group 2: Customs Measures - The customs authority has introduced nine measures to support the cosmetics industry, including a "white list + sampling release" evaluation process for exported cosmetics and reforms in batch inspection [1] - These measures are designed to enhance the efficiency of customs clearance and reduce operational costs for cosmetics companies, particularly benefiting small and medium-sized enterprises [2][3] Group 3: Support for SMEs - The new customs measures create a credit-based regulatory service system that addresses concerns regarding customs efficiency and cost optimization for cosmetics companies [3] - The customs authority is expanding the types and regions for market procurement exports of cosmetics, aiming to open new channels for small and medium-sized enterprises to access international markets [3]

Group 1 - The core event is the launch of JD's "Send New Year Goods to Hometown" campaign in Jiangsu, where over 10,000 items were distributed, including popular skincare products like Baicaohui's mask set [1][3] - Baicaohui's skincare set features a nourishing mask and essential oil, utilizing traditional formulas with carefully selected herbal extracts, aimed at enhancing skin glow and elasticity [3][5] - Other popular products include the Keep G3Air massage gun for muscle relief and a red sock gift box, both designed to cater to consumer needs during the New Year [5][6] Group 2 - JD's New Year shopping festival offers significant discounts across various categories, including fashion and beauty, with promotions such as buy one get three free and exclusive subsidies [6] - The campaign emphasizes the importance of addressing consumer needs with thoughtful products, contributing to the popularity of "Guangming Village" goods [5][6]

安热沙、蜜丝婷防晒产品涉嫌假冒 近期，国家药品监督管理局最新发布的化妆品抽检信息显示，共有45批次化妆品不符合规定，其中涉及 防晒类产品14批次。值得注意的是，2批次知名防晒品牌安热沙、1批次蜜丝婷均被检出防晒霜成分不合 格，且3款产品经鉴别涉嫌系假冒产品。此外，另有11批次防晒产品检出不合格，主要问题集中在缺失 标示防晒剂、添加未标识成分、关键成分含量不足三方面。 抽检信息显示，标称株式会社资生堂生产、资生堂（中国）投资有限公司经销/境内责任人的"安热沙金 灿倍护防晒乳（90ml，标示批号5008L0）"、"安热沙金灿倍护防晒乳（60ml，标示批号5023D7）"检出 不合格。 这两款产品均标示上海（日本进口），普通化妆品备案编号J20200625，不合格原因系未检出标签及注 册资料中标示的多种防晒剂，具体包括双-乙基己氧苯酚甲氧苯基三嗪、二乙氨羟苯甲酰基苯甲酸己 酯、甲氧基肉桂酸乙基己酯、水杨酸乙基己酯、奥克立林等成分。 对此，产品境内责任人资生堂（中国）投资有限公司迅速提出样品真实性异议。经上海市药品监督管理 局核查确认，该企业并未生产或进口过该两批次抽检产品，相关产品涉嫌假冒。对于问题产品的后续处 理 ...

1月30日，彭博称特朗普政府正准备提名凯文·沃什出任美联储主席。特朗普将于北京时间今天晚上宣布 美联储主席人选。预测市场Polymarket最新显示，沃什被特朗普提名为美联储新主席的概率飙升至 95%。 美股频道更多独家策划、专家专栏，免费查阅>> 责任编辑：栎树 凯文·沃既即是美联储资深人士，也是华尔街的资深人士。与鲍威尔和耶伦等前任美联储主席不同，沃 什并非经济学家出身。作为一名律师，沃什在摩根士丹利工作直至2002年，随后进入小布什政府担任中 层经济职位，2006年被任命为美联储理事，直至2011年离任。 沃什的妻子是化妆品巨头雅诗兰黛的直系继承人，岳父罗纳德·兰黛与特朗普是沃顿商学院的同学，是 共和党的主要捐赠者，也是收购格陵兰岛的提议者。特朗普的传记作者Tim O'Brien说过，"任何时候， 只要某人与有权有势或有名的人有联系，对特朗普来说都至关重要。" 凯文·沃什，何许人也？ ...

Core Viewpoint - The brokerage firms have set target prices for listed companies, with 10 stocks showing a target price increase of over 20% based on the latest closing prices [1] Group 1: Target Price Increases - A total of 11 target price adjustments were made by brokerages for listed companies [1] - The companies with the highest target price increases include CATL (Ningde Times) at 75.79%, China Railway at 53.99%, and Shanghai Jahwa at 52.17% [1] - These companies belong to the battery, infrastructure, and cosmetics industries respectively [1]

"海关出台的九条新举措，构建了一套以企业信用为基础的精准高效监管服务体系，精准回应了化妆品 企业在通关效率、成本优化等方面的关切，将为化妆品行业提质升级注入强劲动力。"广州诗妃生物科 技有限公司董事长张申俊表示，海关实施的"合格保证+抽样放行""批次检验"等措施，将进一步缩短货 物通关及整体供应链周转时间，有助于化妆品企业加速订单交付，优化现金流，降低运营成本。 广州海关有关负责人表示，在支持新业态健康发展方面，该海关紧扣美妆产品多元化出海需求，量身定 做市场采购"轻量化"出口路径，为中小微企业开辟出海新通道。在2025年8月华南地区首票市场采购贸 易出口化妆品业务落地广州的基础上，在做好风险评估的前提下，扩大市场采购出口化妆品种类和国家 地区清单，扩大出口覆盖面。同时，聚焦美妆产品展销需求，设置专用通道分类简化参展化妆品入境手 续，推动专业展会保障提质增效。用于化妆品专业类展会中仅供展览的化妆品，免于送实验室检测；适 量试用的化妆品，根据安全风险评估情况，可在展前抽取样品检验。 相关附件 海关出台九条措施支持化妆品产业发展，主要包括实施出口化妆品"白名单+抽样放行"的合格评定程 序、探索出口化妆品"批次检验 ...

Group 1 - The core viewpoint of the article highlights the target price increases for several listed companies, with notable gains for Ningde Times, China Railway, and Shanghai Jahwa, reflecting strong market confidence in these sectors [1][2]. Group 2 - On January 29, the companies with the highest target price increases were Ningde Times (75.79%), China Railway (53.99%), and Shanghai Jahwa (52.17%), indicating significant bullish sentiment in the battery, infrastructure, and cosmetics industries respectively [1][2]. - A total of 27 listed companies received broker recommendations on January 29, with Qingdao Bank receiving the most recommendations at 5, followed by Mingyang Smart Energy and Ruoyuchen with 2 each [1][3]. - Three companies had their ratings upgraded on January 29, including TBEA, which was upgraded from "Hold" to "Buy" by Huatai Securities, reflecting improved outlooks for these firms [4][6]. - Five companies received initial coverage on January 29, with Qingdao Bank rated "Recommended" by Guolian Minsheng Securities, indicating new interest from analysts in these stocks [6][7].

Core Insights - HBN, a leading dermatological skincare brand in China, has submitted its listing application to the Hong Kong Stock Exchange, backed by Morgan Stanley and CICC [1] - The company reported a steady revenue growth, achieving RMB 1.514 billion in revenue for the first three quarters of 2025, a year-on-year increase of 10.2%. Net profit is projected to rise from RMB 39 million in 2023 to RMB 129 million in 2024, with a net profit margin reaching 9.6% in the first three quarters of 2025 [1] Group 1: Business Model and Growth Strategy - HBN adopts a "slow" research-driven approach, distinguishing itself from traditional beauty brands, and is increasingly viewed as a model with anti-cyclical characteristics [3] - The global trend towards professional and effective skincare products positions dermatological cosmetics as a key growth driver in the beauty industry [3] - HBN has built a strong technical moat through years of research investment, resulting in over 4.6 million repeat customers, with average repurchase rates of approximately 35.4% on Tmall and 44.0% on Douyin in 2025 [3] Group 2: Research and Development Capabilities - HBN has established a reusable R&D system that encompasses interdisciplinary basic research, ingredient innovation, product development, and a comprehensive multi-dimensional verification system [4] - The R&D team consists of 103 professionals with expertise in various fields, including dermatology and synthetic biology, enabling cross-disciplinary collaboration [6] - HBN has published 50 papers in SCI-indexed journals, ranking first among domestic skincare brands for first-author publications, and has developed innovative ingredients such as the first A-retinol synthesis component approved in China [6] Group 3: Market Position and Future Potential - The valuation logic in the beauty market is shifting towards assessing future value creation capabilities, with HBN's "slow research" model laying the groundwork for significant growth potential [7] - Each research paper, self-developed ingredient, and patent represents a "technical seed" for future growth, potentially leading to breakthrough product solutions and new growth trajectories [7]